Reliability of the Stryd Accelerometer on an Incline and Decline

Modern technology has evolved to include various health and fitness trackers to help the general population become more aware of their physical wellbeing. However, the reliability of these technologies is not well-established. PURPOSE: Determine the reliability of Stryd accelerometer during trail running. METHODS: Seventeen participants (25 ± 9 years; F = 7) completed a trail run. Each participant was fitted with one Stryd accelerometer (model 25; Stryd, Boulder, CO 80301) on the shoe of each foot, and both devices were started simultaneously. The participant then did a self-paced out and back run on a moderate difficulty hiking trail. The trail began at approximately 6000 feet elevation and climbed approximately 200 feet/mile. After ten minutes of running up the trail, the participant turned around and returned on the same trail. Upon finishing the run, the Stryd accelerometers were stopped simultaneously. Data collected by Stryd sensors includes distance, altitude, speed, power, form power, cadence, vertical oscillation, and leg stiffness. These Stryd data were exported to csv files. We divided the data into uphill and downhill phases of the run based on the peak elevation achieved and found the average and peak values for uphill and downhill phases of the run. We calculated the within-subjects coefficient of variation for each measure during downhill and uphill trail running. RESULTS: Of the mentioned variables, six were considered reliable-each with a CV less than 0.1-and three were considered unreliable-with a CV of over 0.1. The least reliable measures were form power (uphill: CV=0.124; downhill: CV=0.126) and power (uphill: CV=0.132; downhill: CV=0.135). The most reliable measures were cadence (uphill: CV=0.002; downhill: CV=0.005) and altitude (uphill: CV=0.004; downhill: 0.004). CONCLUSION: As the majority of the measures were statistically reliable, the Stryd accelerometer can be considered reliable. However, the power measures were the least reliable. This finding is important because Stryd advertises the ability to track training intensity based on power output. If this data is unreliable in outdoor locations Stryd may provide inaccurate training advice. Based on our findings tracking outdoor run intensity based on Stryd power may provide inconsistent results

Heart Rate and Energy Expenditure Concurrent Validity of Identical Garmin Wrist Watches During Moderately Heavy Resistance Training

Consistent with previous years, ACSM has found that wearable technology and resistance training (RT) are two of the top 5 fitness trends in 2023. Our lab recently found that wrist-worn devices, such as Garmin Instinct, are neither valid nor reliable at measuring average or maximal heart rate (HR) or estimating energy expenditure (EE) following light intensity circuit RT. We postulated that the errors may have been due to the device’s algorithms assuming higher intensity during RT. PURPOSE: The purpose of this study was to determine the concurrent validity of identical Garmin Instinct wrist-watches to record valid measures of average and maximal HR as well as estimated EE following moderately heavy RT. METHODS: Twenty-one adult participants completed this study (n=10 female, n=11 male). Two Garmin Instinct wrist-watches were evaluated, along with the Polar H10 chest strap and Cosmed K5 portable metabolic unit as the criterion devices for average/maximal HR and EE, respectively. Participants completed 8 supersets of the reverse lunge and shoulder press exercises using dumbbells at a light (4 sets) and moderately heavy (4 sets) intensity with 1 superset of 6 repetitions per exercise (12 repetitions per superset) and 1 min rest between supersets. Data were analyzed for validity (Mean Absolute Percent Error [MAPE] and Lin’s Concordance Coefficient [CCC]), with predetermined thresholds of MAPE\u3c10% and CCC\u3e0.70. A one-way repeated measures ANOVA with Sidak post-hoc test was used to determine differences (p\u3c0.05). RESULTS: The identical Garmin Instinct devices were not considered valid for average HR (MAPE range: 36.5-81.6%; CCC range: 0.07-0.18), maximal HR (MAPE range: 18.6-18.8%; CCC range: 0.15-0.31), or estimated EE (MAPE range: 14.0-16.4%; CCC range: 0.08-0.32) compared to the criterion references. The devices were significantly different than each other for average HR (p=0.005), maximal HR (p\u3c0.001), and estimated EE (p\u3c0.0001). CONCLUSION: The wearable wrist-worn devices tested herein should not be utilized for accurate measurements of HR or EE during RT, and there are even differences between identical devices. People who RT while using these devices should do so with caution if wishing to utilize them for physiological measures

Rating of Perceived Exertion, Average Heart Rate, and Energy Expenditure Following Indoor and Outdoor Moderately Heavy Superset Resistance Training

Our lab recently found that light intensity circuit resistance training outdoors had a significantly lower perception of effort (RPE) compared to indoor resistance training, despite no physiological differences in heart rate and energy expenditure. However, no study has examined other intensities or set schemes in differing environmental settings. PURPOSE: To determine how indoor or outdoor environments effect rating of perceived exertion (RPE) following light and moderately heavy intensity superset resistance training in recreationally resistance trained adults. METHODS: Twenty-three adult participants completed this study (n=10 female, n=13 male; age: 26.1±8.8 yrs; height: 172.2±9.5 cm; mass: 73.4±18.7 kg; RT experience: 5.3±4.8 yrs). Participants wore devices to measure heart rate (Polar H10 chest strap) and energy expenditure (Cosmed K5 Portable Metabolic Cart). Randomly in indoor and outdoor settings, participants completed 4 supersets of the reverse lunge and shoulder press exercises using dumbbells at a light (2 sets) and moderately heavy (2 sets) intensity with 1 superset of 6 repetitions per exercise (12 repetitions per superset) and 1 min rest between supersets. The OMNI Rating of Perceived Exertion Scale for Resistance Exercise 0-10 RPE scale was used following each superset. A paired T-test was used to determine differences between environmental setting (pRESULTS: No significant differences were observed between indoor and outdoor environments for average heart rate (129.4±17.2 and 127.8±23.3 bpm, p=0.67), energy expenditure (30.6±11.5 and 28.3±9.9 kcals; p=0.06), as well as RPE during light intensity (2.9±0.9 and 2.9±0.8 arbitrary units/AU’s, p=0.70) and moderately heavy intensity (6.5±1.7 and 6.3±1.5 AU’s, p=0.27) supersets. CONCLUSION: In recreationally resistance trained adults, light intensity and moderately heavy intensity superset resistance training in indoor or outdoor settings does not alter heart rate, energy expenditure, or perceived effort

Evaluation of Average and Maximum Heart Rate of Wrist-worn Wearable Technology Devices During Trail Running

It has been estimated that there are 20 million people who participate in trail running, and these numbers are expected to increase by 15% each year. Our laboratory group has conducted studies on the validity of wearable technology watches and heart rate (HR) during trail running. The previous generation devices were mostly inaccurate, and a limitation was that reliability was not measured. PURPOSE: To determine both validity and reliability in newer models of wearable devices during trail running. METHODS: Seventeen participants (F = 7) ran on the Thunderbird Gardens Lightning Switch trail in Cedar City, UT. Demographic characteristics: Age = 25 (9) years (mean [standard deviation]), ht = 168 (9) cm, mass = 72 (14) kg. Two Garmin Instincts and two Polar Vantage M2s were evaluated, along with the Polar H10 chest strap as the criterion measure. Participants ran out on the trail for 10-minutes, and then returned to the trailhead. Maximum HR and average HR were measured during the run. Data were analyzed for validity (Mean Absolute Percent Error [MAPE] and Lin’s Concordance [CCC]) and reliability (Coefficient of Variation [CV] and Intraclass Correlation Coefficient [ICC]). Predetermined thresholds were: MAPE0.70, CV0.70. RESULTS: The Garmin Instinct met the threshold for both reliability tests for average and maximum HR (see table). The Garmin Instinct and Polar Vantage met the threshold for both validity tests for maximum HR. CONCLUSION: In order for a device to be considered valid, it must meet the predetermined thresholds for both validity and reliability. These results indicate that only the Garmin Instinct is valid and reliable, but only for measuring maximum HR. This is challenging for those who wish to track their HR while trail running, because neither of the studied devices were valid and reliable for maximum and average HR

Average Heart Rate and Energy Expenditure Validity of Garmin Vivoactive 3 and Fenix 6 Wrist Watches During Light Circuit Resistance Training

Our laboratory recently found wrist-worn wearable technology devices to be valid for measuring average heart rate (HR), but not valid for estimated energy expenditure (EE) compared to criterion devices, during steady state aerobic training (walking, running, biking). However, the validity of wrist-worn devices for HR and EE measures during resistance training is largely unknown. PURPOSE: The purpose of this study was to determine if two wrist-worn devices, Garmin Vivoactive 3 and Garmin Fenix 6 Pro, record valid measures of average HR and EE while performing circuit resistance training. METHODS: Twenty participants (n=10 female, n=10 male; age: 23.2 ± 7.7 years) completed this study. The Garmin Vivoactive 3 and Garmin Fenix 6 Pro were tested along with the Polar H10 chest strap and Cosmed K5 portable metabolic unit as the criterions for average HR and EE, respectively. Participants completed 4 circuits of 4 exercises (front squat, reverse lunge, push-ups, and shoulder press) using dumbbells at a light intensity with 1 set of 10 repetitions per exercise and 30 seconds rest between exercises and 1-1.5 min. rest between circuits. Mean absolute percent error (MAPE, ≤10%) and Lin’s Concordance (ρ≥0.7) were used to validate the device’s average HR (in bpm) and estimated EE (in kcals) compared to criterion reference devices. Dependent T-tests determined differences (p≤0.05). RESULTS: Average HR for Garmin Vivoactive 3 and Fenix 6 Pro were significantly different (p\u3c0.01) than the Polar H10 (115.0±23.9 and 124.5±15.4 vs 128.9±19.0 bpm, respectively), and were not considered valid (MAPE: 44.8% and 25.1%; Lin’s Concordance: 0.50 and 0.63, respectively). Estimated EE for Garmin Vivoactive 3 and Fenix 6 Pro were significantly different (p\u3c0.0001) than the Cosmed K5 (31.7±12.3 and 39.7±13.1 vs 20.3±5.5 kcals, respectively), and were not considered valid (MAPE: 309.7% and 322.1%; Lin’s Concordance: 0.04 and 0.15, respectively). CONCLUSION: Anyone involved in any resistance training aspect should be aware of the limitations of these wrist-worn devices in measuring average HR or EE

Raman scattering and FT-IR spectroscopic studies on dithienylethene switches—towards non-destructive optical readout

The non-destructive readout of photochromic memory materials based on the dithienylethene unit both by IR spectroscopy and Raman scattering is explored. A representative series of C5-substituted thienyl hexahydro- and hexafluoro-cyclopentene based photochromes was investigated to explore the effect and potential usefulness of substitution for the development of multicomponent memory materials. The effect of the deposition method on the photochemistry of solid materials containing photochromic dithienylcyclopentene switches was also explored. Photoconversion in the solid state to the closed form was found to be low when starting from the open form, but, in contrast, ring opening to the open state from the closed form was found to be complete. The effect was found to be due to inner filter rather than conformational phenomena. Characteristic vibrational bands for the central dithienyl core are assigned and a comparison made of the vibrational spectroscopic properties of the perhydro- and perfluoro switches. The data enable the determination of the photoconversion achievable in the solid state as well as some assessment of the influence of the deposition method on the photoconversion. The potential of Raman spectroscopy as a method of achieving non-destructive optical readout is demonstrated through the large differences in absolute Raman scattering intensity between the open and closed states, when monitored at wavelengths which do not result in photochemical ring opening.

Anti-cancer potential of MAPK pathway inhibition in paragangliomas-effect of different statins on mouse pheochromocytoma cells.

To date, malignant pheochromocytomas and paragangliomas (PHEOs/PGLs) cannot be effectively cured and thus novel treatment strategies are urgently needed. Lovastatin has been shown to effectively induce apoptosis in mouse PHEO cells (MPC) and the more aggressive mouse tumor tissue-derived cells (MTT), which was accompanied by decreased phosphorylation of mitogen-activated kinase (MAPK) pathway players. The MAPK pathway plays a role in numerous aggressive tumors and has been associated with a subgroup of PHEOs/PGLs, including K-RAS-, RET-, and NF1-mutated tumors. Our aim was to establish whether MAPK signaling may also play a role in aggressive, succinate dehydrogenase (SDH) B mutation-derived PHEOs/PGLs. Expression profiling and western blot analysis indicated that specific aspects of MAPK-signaling are active in SDHB PHEOs/PGLs, suggesting that inhibition by statin treatment could be beneficial. Moreover, we aimed to assess whether the anti-proliferative effect of lovastatin on MPC and MTT differed from that exerted by fluvastatin, simvastatin, atorvastatin, pravastatin, or rosuvastatin. Simvastatin and fluvastatin decreased cell proliferation most effectively and the more aggressive MTT cells appeared more sensitive in this respect. Inhibition of MAPK1 and 3 phosphorylation following treatment with fluvastatin, simvastatin, and lovastatin was confirmed by western blot. Increased levels of CASP-3 and PARP cleavage confirmed induction of apoptosis following the treatment. At a concentration low enough not to affect cell proliferation, spontaneous migration of MPC and MTT was significantly inhibited within 24 hours of treatment. In conclusion, lipophilic statins may present a promising therapeutic option for treatment of aggressive human paragangliomas by inducing apoptosis and inhibiting tumor spread

INNODIA Master Protocol for the evaluation of investigational medicinal products in children, adolescents and adults with newly diagnosed type 1 diabetes

Background The INNODIA consortium has established a pan-European infrastructure using validated centres to prospectively evaluate clinical data from individuals with newly diagnosed type 1 diabetes combined with centralised collection of clinical samples to determine rates of decline in beta-cell function and identify novel biomarkers, which could be used for future stratification of phase 2 clinical trials. Methods In this context, we have developed a Master Protocol, based on the “backbone” of the INNODIA natural history study, which we believe could improve the delivery of phase 2 studies exploring the use of single or combinations of Investigational Medicinal Products (IMPs), designed to prevent or reverse declines in beta-cell function in individuals with newly diagnosed type 1 diabetes. Although many IMPs have demonstrated potential efficacy in phase 2 studies, few subsequent phase 3 studies have confirmed these benefits. Currently, phase 2 drug development for this indication is limited by poor evaluation of drug dosage and lack of mechanistic data to understand variable responses to the IMPs. Identification of biomarkers which might permit more robust stratification of participants at baseline has been slow. Discussion The Master Protocol provides (1) standardised assessment of efficacy and safety, (2) comparable collection of mechanistic data, (3) the opportunity to include adaptive designs and the use of shared control groups in the evaluation of combination therapies, and (4) benefits of greater understanding of endpoint variation to ensure more robust sample size calculations and future baseline stratification using existing and novel biomarkers